Alnylam Pharmaceuticals
ALNY
#459
Rank
C$73.18 B
Marketcap
C$553.98
Share price
-0.28%
Change (1 day)
48.80%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company